BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept
2023 · Annals of the Rheumatic Diseases · 19 citations
https://doi.org/10.1136/ard-2022-223529
Z
Ziwei Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
6.3K
Citations
11
h-index
12
i10-index
Ziwei Hu is an academic researcher from Hangzhou Normal University. The author has contributed to research in topics: IgG4-Related and Inflammatory Diseases & Systemic Lupus Erythematosus Research & Autoimmune Bullous Skin Diseases. The author has an h-index of 11, co-authored 25 publications.
ORCID: 0000-0003-3552-2143Papers by this author
worksClinical and laboratory characteristics of Sjögren’s syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study
2025 · Clinical Rheumatology · 4 citations
https://doi.org/10.1007/s10067-024-07273-z
Eltrombopag for the treatment of refractory connective tissue disease-related thrombocytopenia: a pilot study of 52 cases
2025 · Arthritis Research & Therapy · 3 citations
https://doi.org/10.1186/s13075-024-03472-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat